[HTML][HTML] Updates in the pathologic classification of thyroid neoplasms: a review of the World Health Organization classification

Y Bai, K Kakudo, CK Jung - Endocrinology and Metabolism, 2020 - synapse.koreamed.org
Advances in medical sciences and evidence-based medicine have led to momentous
changes in classification and management of thyroid neoplasms. Much progress has been …

Thyroid cancer incidence trends by histology in 25 countries: a population-based study

A Miranda-Filho, J Lortet-Tieulent, F Bray… - The lancet Diabetes & …, 2021 - thelancet.com
Background The incidence of thyroid cancer has increased in different populations
worldwide in the past 30 years. We present here an overview of international trends of …

Artificial intelligence for personalized medicine in thyroid cancer: current status and future perspectives

LR Li, B Du, HQ Liu, C Chen - Frontiers in Oncology, 2021 - frontiersin.org
Thyroid cancers (TC) have increasingly been detected following advances in diagnostic
methods. Risk stratification guided by refined information becomes a crucial step toward the …

Expanded parameters in active surveillance for low-risk papillary thyroid carcinoma: a nonrandomized controlled trial

AS Ho, S Kim, C Zalt, ML Melany, IE Chen… - JAMA …, 2022 - jamanetwork.com
Importance Unlike for prostate cancer, active surveillance for thyroid cancer has not
achieved wide adoption. The parameters by which this approach is feasible are also not well …

A new risk factor indicator for papillary thyroid cancer based on immune infiltration

Z Yang, X Wei, Y Pan, J Xu, Y Si, Z Min, B Yu - Cell death & disease, 2021 - nature.com
Increasing evidence has indicated a close association between immune infiltration in cancer
and clinical outcomes. However, related research in thyroid cancer is still deficient. Our …

Associations between artificial light at night and risk for thyroid cancer: a large US cohort study

D Zhang, RR Jones, P James, CM Kitahara, Q Xiao - Cancer, 2021 - Wiley Online Library
Background Light at night (LAN) inhibits nighttime secretion of melatonin and may cause
circadian disruption, which may be a risk factor for cancer. Recent studies have linked high …

Site-specific metastasis and survival in papillary thyroid cancer: the importance of brain and multi-organ disease

EA Toraih, MH Hussein, M Zerfaoui, AS Attia… - Cancers, 2021 - mdpi.com
Simple Summary Papillary thyroid cancer (PTC) is the most common subtypes of thyroid
malignancy, and its distant metastasis (DM) is linked with higher mortality. We sought to …

Influence of nomenclature changes on trends in papillary thyroid cancer incidence in the United States, 2000 to 2017

CM Kitahara, JA Sosa, MS Shiels - The Journal of Clinical …, 2020 - academic.oup.com
Context US papillary thyroid carcinoma (PTC) incidence recently declined for the first time in
decades, for reasons that remain unclear. Objective This work aims to evaluate PTC …

Strategies for radioiodine treatment: what's new

C Sparano, S Moog, J Hadoux, C Dupuy, A Al Ghuzlan… - Cancers, 2022 - mdpi.com
Simple Summary Radioactive iodine treatment is the oldest targeted therapy for
differentiated thyroid cancer. It can be used for normal thyroid remnant ablation (in order to …

Clinical significance and diagnostic value of QPCT, SCEL and TNFRSF12A in papillary thyroid cancer

T Liang, X Wu, L Wang, Z Ni, Y Fan, P Wu… - … -Research and Practice, 2023 - Elsevier
Purpose To identify specific novel genes that could be used as diagnostic and prognostic
factors in papillary thyroid carcinoma (PTC). Methods Screening of differential genes by …